Elevance Health (NYSE:ELV) Issues FY 2026 Earnings Guidance

Posted by Francis Steltz on Sep 19th, 2026

Elevance Health (NYSE:ELV – Get Free Report) issued an update on its FY 2026 earnings guidance on Saturday. The company provided earnings per share guidance of 27.000- for the period, compared to the consensus earnings per share estimate of 27.160. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on ELV. Guggenheim raised their price target on Elevance Health from $399.00 to $455.00 and gave the stock a “buy” rating in a research report on Thursday, July 16th. Leerink Partners lifted their target price on Elevance Health from $364.00 to $395.00 and gave the stock a “market perform” rating in a report on Friday, July 17th. Bank of America boosted their price objective on Elevance Health from $435.00 to $460.00 and gave the company a “buy” rating in a report on Thursday, June 4th. Royal Bank Of Canada decreased their price objective on shares of Elevance Health from $439.00 to $424.00 and set a “sector perform” rating for the company in a research report on Thursday, July 16th. Finally, Sanford C. Bernstein set a $488.00 price target on shares of Elevance Health in a research note on Thursday, July 16th. Fifteen investment analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat, Elevance Health has a consensus rating of “Moderate Buy” and a consensus price target of $440.90.

Check Out Our Latest Stock Analysis on ELV

Elevance Health Stock Performance

Shares of ELV opened at $410.71 on Friday. The company’s 50 day simple moving average is $397.09 and its 200-day simple moving average is $369.87. Elevance Health has a 12-month low of $274.84 and a 12-month high of $436.24. The firm has a market cap of $89.07 billion, a PE ratio of 18.25, a price-to-earnings-growth ratio of 2.16 and a beta of 0.69. The company has a current ratio of 1.52, a quick ratio of 1.52 and a debt-to-equity ratio of 0.68.

Elevance Health (NYSE:ELV – Get Free Report) last issued its quarterly earnings results on Wednesday, July 15th. The company reported $7.45 earnings per share for the quarter, topping the consensus estimate of $6.21 by $1.24. The firm had revenue of $49.83 billion during the quarter, compared to the consensus estimate of $48.88 billion. Elevance Health had a return on equity of 14.64% and a net margin of 2.47%.The company’s revenue for the quarter was up .8% on a year-over-year basis. During the same period last year, the company earned $8.84 earnings per share. As a group, equities analysts predict that Elevance Health will post 27.18 EPS for the current year.

Elevance Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Thursday, September 10th will be issued a $1.72 dividend. This represents a $6.88 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Thursday, September 10th. Elevance Health’s payout ratio is presently 30.58%.

Elevance Health Company Profile

(Get Free Report)

Elevance Health, Inc is a health benefits and services company that provides health insurance, care management and related healthcare solutions in the United States. The company serves individuals, employers and government-sponsored programs through a portfolio that includes commercial health plans, Medicare Advantage and other Medicare products, Medicaid plans, and specialty coverage.

Elevance Health operates a portfolio of Blue Cross Blue Shield-affiliated health plans and offers products such as medical, pharmacy, dental and vision benefits.